Varlilumab Biosimilar: Enhancing Immune Activation via CD27-Targeted Therapy Varlilumab is a monoclonal antibody targeting CD27, a critical costimulatory receptor … read more 5th Dec 2024 Shanza Riaz
Brentuximab Biosimilar: Advancing CD30-Targeted Therapy Brentuximab vedotin is a CD30-targeting antibody-drug conjugate (ADC) approved for tre … read more 5th Dec 2024 Shanza Riaz
Biosimilar: Expanding Access to Monoclonal Antibody-Based Therapies 1. What is a Biosimilar? A biosimilar is a biologic medical product that is highl … read more 5th Dec 2024 Shanza Riaz
